Kevin Charles Gorman
CIK: 0001201096
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (32 total)
- Sep 11, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Award(A)Direct14.3K shares- - Sep 11, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Tax Payment(F)Direct7.8K shares at avg. $156.22$1.2M - Jun 16, 2026XNCR
Xencor Inc
Award(A)Direct10.3K shares- - Jun 15, 2026XNCR
Xencor Inc
Sale(S)Direct7.5K shares at avg. $12.31$93K - May 27, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Award(A)DirectNon-Qualified Stock Option
5.2K shares- - May 19, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Sale(S)Direct245.1K shares at avg. $154.33$37.8M - May 19, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Exercise(M)Direct205.1K shares at avg. $43.24$8.9M - Feb 13, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Tax Payment(F)Direct3K shares at avg. $124.12$375K - Feb 13, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Exercise(M)Direct5.6K shares- - Feb 13, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Exercise(M)Direct5.4K shares- - Feb 13, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Tax Payment(F)Direct2.9K shares at avg. $124.12$360K - Feb 13, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Award(A)Direct63.7K shares- - Feb 13, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Tax Payment(F)Direct34.4K shares at avg. $124.12$4.3M - Jan 31, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Exercise(M)Direct5.1K shares- - Jan 31, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Tax Payment(F)Direct2.8K shares at avg. $136.06$387K - Aug 7, 2025NBIX
NEUROCRINE BIOSCIENCES INC
Sale(S)Direct106.3K shares at avg. $126.41$13.4M - Aug 7, 2025NBIX
NEUROCRINE BIOSCIENCES INC
Exercise(M)Direct106.3K shares at avg. $35.99$3.8M - Jun 16, 2025XNCR
Xencor Inc
Sale(S)Direct3.2K shares at avg. $9.22$29K - Jun 12, 2025XNCR
Xencor Inc
Award(A)Direct13.7K shares- - May 27, 2025NBIX
NEUROCRINE BIOSCIENCES INC
Sale(S)Direct9.6K shares at avg. $120.38$1.2M - May 21, 2025NBIX
NEUROCRINE BIOSCIENCES INC
Award(A)DirectNon-Qualified Stock Option
6.6K shares- - Feb 13, 2025NBIX
NEUROCRINE BIOSCIENCES INC
Sale(S)Direct3K shares at avg. $116.68$351K - Feb 13, 2025NBIX
NEUROCRINE BIOSCIENCES INC
Exercise(M)Direct5.4K shares- - Feb 13, 2025NBIX
NEUROCRINE BIOSCIENCES INC
Sale(S)Direct2.8K shares at avg. $116.69$330K - Feb 13, 2025NBIX
NEUROCRINE BIOSCIENCES INC
Exercise(M)Direct5.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 11, 2026 |  NBIX NEUROCRINE BIOSCIENCES INC | Award(A) | 14,343 | - | $0 | Direct |
| Sep 11, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Tax Payment(F) | 7,839 | $156.22 | $1,224,609 | Direct |
| Jun 16, 2026 |  XNCR Xencor Inc | Award(A) | 10,302 | - | $0 | Direct |
| Jun 15, 2026 | XNCR Xencor Inc | Sale(S) | 7,527 | $12.31 | $92,657 | Direct |
| May 27, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Award(A) Non-Qualified Stock Option | 5,248 | - | - | Direct |
| May 19, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Sale(S) | 245,088 | $154.33 | $37,824,872 | Direct |
| May 19, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise(M) | 205,088 | $43.24 | $8,868,005 | Direct |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Tax Payment(F) | 3,024 | $124.12 | $375,339 | Direct |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise(M) | 5,604 | - | $0 | Direct |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise(M) | 5,377 | - | $0 | Direct |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Tax Payment(F) | 2,901 | $124.12 | $360,072 | Direct |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Award(A) | 63,724 | - | $0 | Direct |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Tax Payment(F) | 34,380 | $124.12 | $4,267,246 | Direct |
| Jan 31, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise(M) | 5,142 | - | $0 | Direct |
| Jan 31, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Tax Payment(F) | 2,845 | $136.06 | $387,091 | Direct |
| Aug 7, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | Sale(S) | 106,322 | $126.41 | $13,440,281 | Direct |
| Aug 7, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise(M) | 106,322 | $35.99 | $3,826,529 | Direct |
| Jun 16, 2025 | XNCR Xencor Inc | Sale(S) | 3,173 | $9.22 | $29,255 | Direct |
| Jun 12, 2025 | XNCR Xencor Inc | Award(A) | 13,686 | - | - | Direct |
| May 27, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | Sale(S) | 9,613 | $120.38 | $1,157,211 | Direct |
| May 21, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | Award(A) Non-Qualified Stock Option | 6,610 | - | - | Direct |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | Sale(S) | 3,012 | $116.68 | $351,450 | Direct |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise(M) | 5,376 | - | - | Direct |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | Sale(S) | 2,832 | $116.69 | $330,465 | Direct |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise(M) | 5,603 | - | - | Direct |
1-25 of 32 transactions
About GORMAN KEVIN CHARLES
GORMAN KEVIN CHARLES (SEC CIK 0001201096) files insider reports with the SEC as Director of NEUROCRINE BIOSCIENCES INC (NBIX) and Director of Xencor Inc (XNCR).
Signal8 holds 16 ownership filings by GORMAN KEVIN CHARLES, all Form 4s, filed between Oct 1, 2024 and Sep 15, 2026. Those filings report 32 transactions, from Sep 27, 2024 to Sep 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on GORMAN KEVIN CHARLES's filings is in SAN DIEGO, CA.
Recent filings by GORMAN KEVIN CHARLES
- Sep 11, 2026: Grant or award of NBIX shares (Form 4, code A).
- Sep 11, 2026: Tax withholding of NBIX shares (Form 4, code F).
- Jun 16, 2026: Grant or award of XNCR shares (Form 4, code A).
- Jun 15, 2026: Open-market sale of XNCR shares (Form 4, code S).
- May 27, 2026: Grant or award of NBIX derivative securities (Form 4, code A).
Other insiders filing for NEUROCRINE BIOSCIENCES INC (NBIX)
- MORROW GEORGE J, Director
- Gano Kyle, Chief Executive Officer
- ROBERTS EIRY, Chief Medical Officer
- Onyia Jude, Chief Scientific Officer
- Lippoldt Darin, Chief Legal Officer
- Keswani Sanjay Chandru, Chief Medical Officer